Peter Damman

Physiological Basis and Long-Term Clinical Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve in Coronary Stenoses of Intermediate Severity

Tim P. van de Hoef, Martijn A. van Lavieren, Peter Damman et al. · Circulation Cardiovascular Interventions · 2014 · 372 citations

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 142 citations · Full text

5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial

Peter Damman, Alexander Hirsch, Fons Windhausen et al. · Journal of the American College of Cardiology · 2010 · 132 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Vascular Surgery +11

Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessment

Tim P. van de Hoef, Froukje Nolte, Mauro Echavarría‐Pinto et al. · Heart · 2014 · 120 citations

Multiple Biomarkers at Admission Significantly Improve the Prediction of Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction

Peter Damman, Marcel A.M. Beijk, Wichert J. Kuijt et al. · Journal of the American College of Cardiology · 2010 · 100 citations

Biomarker Research, Percutaneous Coronary Intervention, Cardiovascular Disease +12